Immunoreactive peptide ctl epitopes of human cytomegalovirus pp150
CA 2425202 C · Owner: Diamond, Don J. · Inventors: Diamond, Don J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides peptides which are immunogenic epitopes recognized by CD8+ class I MHC restricted cytotoxic T-lymphocytes of patients harboring latent cytomegalovirus (HCMV) infection. The peptides are capable of activating CTL in the absence of active viral replication and thus are useful , for eliciting a cellular immune response against HCMV by normal and immunodeficient subjects. Vaccines against HCMV with and without adjuvants, and immunological and diagnostic reagents are disclosed.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 22, 2001 and granted January 3, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended October 22, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 22, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.